Christopher R. Fortier, PharmD, FASHP, Chief Pharmacy Officer, Massachusetts General Hospital, Partners HealthCare (Mass General Brigham). Healthcare providers are vulnerable to serious legal, financial, operational and reputational risks – and regulatory fines – due to employee drug diversion and inadequate internal controls. COVID-19 has increased employee’s feelings of stress and burnout has spiked to new levels. Furthermore, mounting evidence is showing the pandemic is increasing substance abuse across the country. To avoid potential risks, providers can use machine-learning algorithms together with advanced diversion prevention software to gain real-time dashboard views into their controlled substance supply chain to analyze behavior patterns among problem areas and suspected individuals. This teleconference will be insightful for all leaders, particularly IT and clinical leaders.